• McEwen Inc. recently reported its Year-End 2025 Mineral Resource Estimate for the Grey Fox Project in Ontario, lifting Indicated gold resources to 1.9 million ounces and outlining plans to accelerate underground and open-pit mining, while also advancing the Tartan Mine and El Gallo Fenix projects.
• Beyond the headline resource growth, McEwen’s verification drilling at the newly acquired Stroud Property and the upcoming Grey Fox pre-feasibility study point to an integrated, multi-asset build-out across Canada and Mexico that could reshape the company’s project pipeline.
• We’ll now examine how Grey Fox’s larger resource base and early underground mining scenarios shape McEwen’s broader investment narrative.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

What Is McEwen's Investment Narrative?

To own McEwen today, you have to believe in its ability to convert a growing project pipeline into sustainable cash flow, despite a rich valuation and ongoing losses. The latest Grey Fox resource upgrade, plus momentum at Stroud, Tartan and El Gallo Fenix, reinforces a near term catalyst set that is now squarely about studies, permits and construction decisions rather than blue sky exploration. With the stock already pricing in a lot of optimism and trading above some earlier fair value estimates, the key question is whether upcoming milestones like the Grey Fox pre feasibility study, the Tartan resource update and Fenix build out can support that enthusiasm. If these slip, the same operational leverage that has helped recent returns could work in reverse.

However, McEwen’s premium pricing and execution risk are exactly what investors need to watch.
McEwen's shares are on the way up, but could they be overextended? Uncover how much higher they are than fair value.

Exploring Other Perspectives

Six fair value estimates from the Simply Wall St Community span roughly US$8.69 to US$35.89, underscoring how differently people see McEwen’s upside as Grey Fox, Tartan and Fenix execution risks come into focus.

Explore 6 other fair value estimates on McEwen - why the stock might be worth as much as 34% more than the current price!

Build Your Own McEwen Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your McEwen research is our analysis highlighting 1 key reward that could impact your investment decision.
• Our free McEwen research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate McEwen's overall financial health at a glance.

Searching For A Fresh Perspective?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 109 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.